Endocrine Tumors

Oncology·MeSH: Neuroendocrine Tumors

20 drugs in development·12 companies·1 clinical trial

Drug Pipeline by Phase

Approved(3)

Phase 3(4)

Drug	Company
177lu-pnt2003	POINT Biopharma Global Inc. (PNT)
lutetium[177lu] oxodotreotide	SPRING PHARMACEUTICAL GROUP, INC. (CYIG)
octreotide lar	SPRING PHARMACEUTICAL GROUP, INC. (CYIG)
pnt2003	POINT Biopharma Global Inc. (PNT)

Phase 2(4)

Drug	Company
Aldesleukin	Twist Bioscience Corp (TWST)
Fludarabine	Twist Bioscience Corp (TWST)
fyarro	Whitehawk Therapeutics, Inc. (WHWK)
Individual Patient TCR-Transduced PBL	Twist Bioscience Corp (TWST)

Phase 1(1)

Drug	Company
pelcitoclax	ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)

Preclinical(1)

Drug	Company
Pb212-VMT-⍺-NET	Lantheus Holdings, Inc. (LNTH)

BLA Filed(1)

Drug	Company
PNT2003	Lantheus Holdings, Inc. (LNTH)

N/A(1)

Drug	Company
Pb212-VMT-α-NET	Lantheus Holdings, Inc. (LNTH)

Phase 1/Phase 2(3)

Drug	Company
[203pb]vmt-α-net	Perspective Therapeutics, Inc. (CATX)
[212pb]vmt-α-net	Perspective Therapeutics, Inc. (CATX)
VMT-α-NET	Perspective Therapeutics, Inc. (CATX)

Phase 2/Phase 3(2)

Drug	Company
surufatinib	HUTCHMED (China) Ltd (HMDCF)
surufatinib	HUTCHMED (China) Limited (HCM)

BioSniper tracks 20 drugs in development for Endocrine Tumors across 12 companies.

There are 1 clinical trial targeting Endocrine Tumors tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.